International Primary Ciliary Dyskinesia (PCD) Registry

NCT02419365 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-11-28

No results posted yet for this study

Summary

The purpose of the international prospective PCD Patient Registry is to systematically measure, survey and compare different aspects of PCD manifestation, course and treatment, to provide data for epidemiological research and to identify special patient groups suitable for multi-center trials.

This International PCD Registry is also part of the European Reference Network ERN-LUNG. We follow the recommendations of the EU Expert Committee on Rare Diseases (EUCERD), which recommend an international interoperability of registries and databases to pool and exchange knowledge and data on rare diseases.

Conditions

  • Primary Ciliary Dyskinesia (PCD)

Sponsors & Collaborators

  • European Commission

    collaborator OTHER
  • University of Nicosia

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • KU Leuven

    collaborator OTHER
  • Hannover Medical School

    collaborator OTHER
  • Attikon Hospital

    collaborator OTHER
  • Amsterdam UMC, location VUmc

    collaborator OTHER
  • University of Bern

    collaborator OTHER
  • University of Southampton

    collaborator OTHER
  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • Ruhr University of Bochum

    collaborator OTHER
  • Federico II University

    collaborator OTHER
  • Hospital Vall d'Hebron

    collaborator OTHER
  • Medical University of Vienna

    collaborator OTHER
  • Marmara University

    collaborator OTHER
  • University Hospital, Martin

    collaborator OTHER
  • University of Pisa

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • University of Giessen

    collaborator OTHER
  • University Hospital Muenster

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02419365 on ClinicalTrials.gov